AXQ Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,559
| Closed | -$1.22M | – | 566 |
|
|
2024
Q3 | $1.22M | Buy |
10,559
+7,415
| +236% | +$854K | 0.37% | 86 |
|
|
2024
Q2 | $433K | Buy |
3,144
+1,624
| +107% | +$224K | 0.1% | 321 |
|
|
2024
Q1 | $210K | Sell |
1,520
-6,780
| -82% | -$935K | 0.05% | 507 |
|
|
2023
Q4 | $1.09M | Sell |
8,300
-1,600
| -16% | -$211K | 0.29% | 97 |
|
|
2023
Q3 | $1.11M | Buy |
+9,900
| New | +$1.11M | 0.39% | 74 |
|